PT  - JOURNAL ARTICLE
AU  - Lee, Serin
AU  - Zabinsky, Zelda B.
AU  - Kofsky, Stephen
AU  - Liu, Shan
TI  - COVID-19 Pandemic Response Simulation: Impact of Non-pharmaceutical Interventions on Ending Lockdowns
AID  - 10.1101/2020.04.28.20080838
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.28.20080838
4099  - http://medrxiv.org/content/early/2020/05/04/2020.04.28.20080838.short
4100  - http://medrxiv.org/content/early/2020/05/04/2020.04.28.20080838.full
AB  - As many federal and state governments are starting to ease restrictions on non-pharmaceutical interventions (NPIs) used to flatten the curve, we developed an agent-based simulation to model the incidence of COVID-19 in King County, WA under several scenarios. While NPIs were effective in flattening the curve, any relaxation of social distancing strategies yielded a second wave. Even if daily confirmed cases dropped to one digit, daily incidence can peak again to 874 cases without import cases. Therefore, policy makers should be very cautious in reopening society.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAcknowledgement: This work has been supported in part by the National Science Foundation grant CMMI-1935403, and the University of Washington Graduate School Fund for Excellence and Innovation (GSFEI) Top Scholar Award.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in the simulation model are from publicly available literature.